OCUL
OCULAR THERAPEUTIX, INC
NASDAQ · Healthcare · Biotechnology · US
$9.99
−1.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 38.45x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.22x
- Price / sales
- 42.15x
- Price / cash flow
- -9.21x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 32.17x
- EV / EBITDA
- -5.88x
- EV / EBIT
- -5.34x
- Market cap
- $2.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026